Scheduled international flights to remain suspended till February 28

WHO: Covid Strain first found in India to be called 'Delta' variant

Rhizen Pharmaceuticals Announces US FDA Acceptance of its IND Application for RP7214 in SARS-CoV-2 Infection

<p>Phase 1 Clinical Trial of RP7214 Set to Begin Early December 2020 Rhizen Pharmaceuticals S.A., an associate company of Alembic Pharmaceuticals Ltd., which is a clinical-stage oncology-focussed biopharmaceutical company, announced the approval of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) to study its oral DHODH inhibitor for SARS-CoV-2 […]</p>